Search Result

Isoforms Recommended:	TNFRSF8/CD30

Results for "

cd30

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (1) Antibody-Drug Conjugates (ADCs) (1) Apoptosis (3) Drug-Linker Conjugates for ADC (1) MMP (1) Small Interfering RNA (siRNA) (3) TNF Receptor (8) Topoisomerase (1)
By Research Areas:	Cancer (11) Inflammation/Immunology (2)
Oligonucleotides:	Aptamers (1) Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Targets Recommended: CD1 CD38 CD28 CD19 CD20 CD22 Transferrin Receptor CD3 P-selectin CD6 CD2 CD276/B7-H3 CD73 c-Kit LAG-3 L-Selectin CTLA-4 CD47 ALCAM/CD166 Neprilysin E-Selectin Scavenger Receptor Class B type I (SR-BI） FLT3 Tim3 CD44 Anaplastic lymphoma kinase (ALK) CD74 Human leukocyte immunoglobulin (Ig)-like receptors (LILR) P-glycoprotein

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99107A

Brentuximab vedotin (solution) 1 Publications Verification	Antibody-Drug Conjugates (ADCs) Apoptosis	Cancer
Brentuximab vedotin (solution) (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). The antibody portion is Brentuximab (HY-P99151), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Brentuximab vedotin (solution) inhibits *CD30*-positive cells with an IC₅₀ of 2.5 ng/mL. Brentuximab vedotin (solution) can be used for the research of relapsed and refractory Hodgkin lymphoma .

HY-P99151

Brentuximab 1 Publications Verification CAC-10	ADC Antibody TNF Receptor	Cancer
Brentuximab (CAC-10) is a chimeric antibody targeting *CD30*. Brentuximab is conjugated with Monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107A). Brentuximab can be used for the research of cancer, such as lymphoma .

HY-P990710

Acimtamig AFM13	TNF Receptor	Cancer
Acimtamig (AFM13) is a *CD30/CD16A* bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL) .

HY-P99669

Iratumumab MDX-060	TNF Receptor	Cancer
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of *CD30*-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .

HY-160649

MC-Gly-Gly-Phe-Gly-GABA-Exatecan	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC₅₀ of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .

HY-P991638

XmAb-2513	TNF Receptor	Cancer
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting *CD30*. XmAb-2513 has significant anti-proliferative activity and superior antibody-dependent cell-mediated cytotoxicity (ADCC) as well as antibody-dependent cell-mediated phagocytosis (ADCP). XmAb-2513 can be used for hematologic malignancies like Hodgkin Lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL) research .

HY-P991553

HeFi-1	TNF Receptor Apoptosis	Inflammation/Immunology Cancer
HeFi-1 is a mouse anti-CD30 IgG1 monoclonal antibody. HeFi-1 recognizes the ligand-binding site on CD30. HeFi-1 can inhibit the growth of tumor cells with high expression of CD30. HeFi-1 can induce eosinophil apoptosis. HeFi-1 can be used for researches on cancer or inflammation conditions such as anaplastic large-cell lymphoma (ALCL) and asthma .

HY-P991512

SGN-30	Apoptosis	Cancer
SGN-30 is a chimeric antibody derived from a mouse antihuman *CD30* antibody, AC10, with the variable regions of AC10 and human α 1 heavy chain and κ light chain constant regions. SGN-30 induces apoptosis and cell-cycle arrest in cancer cells. SGN-30 can be used for the study of Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .

HY-177823

C2NP sodium	TNF Receptor	Cancer
C2NP sodium is a single-strand DNA aptamer that targets CD30. The multivalent C2NP is able to induce oligomerization of CD30 receptors and, in effect, activate downstream signaling, which led to apoptosis of anaplastic large cell lymphoma (ALCL) cells.

HY-180412

Solimastat BB-3644	MMP	Cancer
Solimastat (BB-3644) is a potent metalloproteinase (MMP) inhibitor that blocks constitutive and antibody-stimulated CD30 shedding from cell surfaces with an IC₅₀ of 180 nM. Solimastat enhances persistence of anti-CD30 antibody Ki-3 on cells and favors its internalization. Solimastat enhances cytotoxic activity of Ki-3.dgA towards CD30 ⁺ L540 cells. Solimastat can be used for the research of CD30 ⁺ malignancies .

HY-P992404

MDX-1401	TNF Receptor	Cancer
MDX-1401 is a fully human IgG1 (κ isotype) monoclonal antibody against *CD30, with a K_d* value of 0.83 nmol/L. MDX-1401 induces antibody-dependent cellular cytotoxicity in *CD30*-expressing cells and inhibits tumor growth in *CD30* ⁺ lymphoma xenograft models. MDX-1401 can be used in research related to malignant lymphoma and Hodgkin lymphoma .

HY-RS25069

Tnfrsf8 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tnfrsf8 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf8 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tnfrsf8 Rat Pre-designed siRNA Set A Tnfrsf8 Rat Pre-designed siRNA Set A

HY-RS14816

TNFRSF8 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TNFRSF8 Human Pre-designed siRNA Set A contains three designed siRNAs for TNFRSF8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TNFRSF8 Human Pre-designed siRNA Set A TNFRSF8 Human Pre-designed siRNA Set A

HY-P991909

*Anti-CD30L Antibody*	TNF Receptor	Inflammation/Immunology
Anti-CD30L Antibody is an antibody against human *CD30L*. Recommend Isotype Controls:?Human IgG1 kappa, Isotype Control (HY-P99001).

HY-RS18584

Tnfrsf8 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tnfrsf8 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf8 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tnfrsf8 Mouse Pre-designed siRNA Set A Tnfrsf8 Mouse Pre-designed siRNA Set A

Cat. No.	Product Name	Target	Research Area	Image

HY-P99151

Brentuximab 1 Publications Verification CAC-10	ADC Antibody TNF Receptor	Cancer
Brentuximab (CAC-10) is a chimeric antibody targeting *CD30*. Brentuximab is conjugated with Monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107A). Brentuximab can be used for the research of cancer, such as lymphoma .

HY-P990710

Acimtamig AFM13	TNF Receptor	Cancer
Acimtamig (AFM13) is a *CD30/CD16A* bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL) .

HY-P99669

Iratumumab MDX-060	TNF Receptor	Cancer
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of *CD30*-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .

HY-P991638

XmAb-2513	TNF Receptor	Cancer
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting *CD30*. XmAb-2513 has significant anti-proliferative activity and superior antibody-dependent cell-mediated cytotoxicity (ADCC) as well as antibody-dependent cell-mediated phagocytosis (ADCP). XmAb-2513 can be used for hematologic malignancies like Hodgkin Lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL) research .

HY-P991553

HeFi-1	TNF Receptor Apoptosis	Inflammation/Immunology Cancer
HeFi-1 is a mouse anti-CD30 IgG1 monoclonal antibody. HeFi-1 recognizes the ligand-binding site on CD30. HeFi-1 can inhibit the growth of tumor cells with high expression of CD30. HeFi-1 can induce eosinophil apoptosis. HeFi-1 can be used for researches on cancer or inflammation conditions such as anaplastic large-cell lymphoma (ALCL) and asthma .

HY-P991512

SGN-30	Apoptosis	Cancer
SGN-30 is a chimeric antibody derived from a mouse antihuman *CD30* antibody, AC10, with the variable regions of AC10 and human α 1 heavy chain and κ light chain constant regions. SGN-30 induces apoptosis and cell-cycle arrest in cancer cells. SGN-30 can be used for the study of Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .

HY-P992404

MDX-1401	TNF Receptor	Cancer
MDX-1401 is a fully human IgG1 (κ isotype) monoclonal antibody against *CD30, with a K_d* value of 0.83 nmol/L. MDX-1401 induces antibody-dependent cellular cytotoxicity in *CD30*-expressing cells and inhibits tumor growth in *CD30* ⁺ lymphoma xenograft models. MDX-1401 can be used in research related to malignant lymphoma and Hodgkin lymphoma .

HY-P991909

*Anti-CD30L Antibody*	TNF Receptor	Inflammation/Immunology
Anti-CD30L Antibody is an antibody against human *CD30L*. Recommend Isotype Controls:?Human IgG1 kappa, Isotype Control (HY-P99001).

Recombinant Proteins Recommended:

CD30

Species:	Human (13) Rat (2) Mouse (1) Cynomolgus (4)
Tag:	His (12) Tag Free (2) Avi (3) Myc (1) Fc (7)
Source:	HEK293 (19) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P70075

	CD30/TNFRSF8 Protein, Mouse (HEK293, His) rMuTumor necrosis factor receptor superfamily member 8/TNFRSF8, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Lymphocyte activation antigen cd30; cd30; Tnfrsf8	Mouse	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70023

	CD30/TNFRSF8 Protein, Human (HEK293, His) 1 Publications Verification rHuTumor necrosis factor receptor superfamily member 8/cd30, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; cd30; TNFRSF8	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (HEK293, His) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P700433

	CD30/TNFRSF8 Protein, Human (HEK293, N-His, C-Myc) rHuTumor necrosis factor receptor superfamily member 8/cd30, His; Tumor necrosis factor receptor superfamily member 8; cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; cd30; TNFRSF8	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (HEK293, N-His, C-Myc) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-Myc, N-10*His labeled tag.

HY-P705115

	CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, Fc-Avi) cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; TNFRSF8	Human	HEK293

HY-P701265

	*FITC-Labeled CD30/TNFRSF8 Protein, Human (HEK293, Fc)* TNFRSF8; cd30; D1S166E; Ki-1	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. FITC-Labeled CD30/TNFRSF8 Protein, Human (HEK293, Fc) is the recombinant human-derived FITC-Labeled CD30/TNFRSF8 protein, expressed by HEK293 , with His labeled tag.

HY-P72354

	CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His-Avi) cd30L receptor; Ki-1 antigen; Lymphocyte activation antigen cd30; TNFRSF8	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-6*His, C-Avi labeled tag.

HY-P700673

	CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) cd30; cd30KI-1; cd30L receptor; TNFRSF8; D1S166EKi-1; cd30KI-1	Cynomolgus	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Cynomolgus (HEK293, C-His) is the recombinant cynomolgus-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag.

HY-P78405

	CD30 Ligand/TNFSF8 Protein, Human (HEK293, mFc) cd153; cd30 Ligand; cd30L; cd30-L; cd30LGMGC138144; TNFSF8; cd30LG	Human	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, mFc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal mFc-tag.

HY-P75639

	CD30 Ligand/TNFSF8 Protein, Rat (HEK293) TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8	Rat	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in rat contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30L Protein, Cynomolgus (HEK293, Fc) is 172 amino acids in length (Q66-D237) and is expressed in the HEK293 cells with tag free.

HY-P700036AF

	*Animal-Free CD30* Ligand/TNFSF8 Protein, Human (His)** soluble cd30 Ligand; Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG	Human	E. coli
	CD30 ligand/TNFSF8 protein is a cytokine that specifically binds to TNFRSF8/CD30 and acts as a potent inducer of T cell proliferation. As a homotrimer, this ligand plays a crucial role in regulating T cell activation and growth, contributing to the dynamic coordination of immune responses. Animal-Free CD30 Ligand/TNFSF8 Protein, Human (His) is the recombinant human-derived animal-FreeCD30 Ligand/TNFSF8 protein, expressed by E. coli , with C-His labeled tag. This product is for cell culture use only.

HY-P75640

	CD30 Ligand/TNFSF8 Protein, Rat (HEK293, Fc) TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8	Rat	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in rat contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Rat (HEK293, Fc) is 172 amino acids in length (Q66-D237) and is expressed in the HEK293 cells with a N-terminal hFc-tag.

HY-P77322

	CD30 Ligand/TNFSF8 Protein, Cynomolgus (HEK293, His) TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8	Cynomolgus	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in cynomolgus contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Cynomolgus (HEK293, His) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal His-tag.

HY-P77321

	CD30 Ligand/TNFSF8 Protein, Cynomolgus (HEK293, hFc) TNF superfamily member 8; cd153; cd30 Ligand; TNFSF8	Cynomolgus	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in cynomolgus contains a transmembrane domain belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Cynomolgus (HEK293, hFc) is expressed in the HEK293 cells with a N-terminal hFc-tag.

HY-P76224

	CD30 Ligand/TNFSF8 Protein, Human (HEK293) Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG	Human	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with tag free.

HY-P76225

	CD30 Ligand/TNFSF8 Protein, Human (HEK293, hFc) Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG	Human	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, Fc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal hFc-tag.

HY-P700434

	CD30 Ligand/TNFSF8 Protein, Human (HEK293, N-His) Tumor necrosis factor ligand superfamily member 8; cd153; cd30L; cd30LG	Human	HEK293
	CD30 ligand/TNFSF8 protein is a cytokine that specifically binds to TNFRSF8/CD30 and acts as a potent inducer of T cell proliferation. As a homotrimer, this ligand plays a crucial role in regulating T cell activation and growth, contributing to the dynamic coordination of immune responses. CD30 Ligand/TNFSF8 Protein, Human (HEK293, N-His) is the recombinant human-derived CD30 Ligand/TNFSF8 protein, expressed by HEK293 , with N-6*His labeled tag.

HY-P75421

	CD30/TNFRSF8 Protein, Human (HEK293, hFc) cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (HEK293, hFc) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P75422

	CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His) cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag.

HY-P78406

	CD30/TNFRSF8 Protein, Human (HEK293, His-Avi) cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen	Human	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Human (HEK293, His-Avi) is the recombinant human-derived CD30/TNFRSF8, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of CD30/TNFRSF8 Protein, Human (HEK293, His-Avi) is 361 a.a..

HY-P76792

	CD30/TNFRSF8 Protein, Cynomolgus (194a.a, HEK293, His) cd30L receptor; Tumor necrosis factor receptor superfamily member 8; Ki-1 antigen	Cynomolgus	HEK293
	CD30/TNFRSF8 protein (TNFSF8/CD30L receptor) is a key factor regulating cell growth and lymphoblast transformation and may activate NF-kappa-B signaling. CD30/TNFRSF8 Protein, Cynomolgus (194a.a, HEK293, His) is the recombinant cynomolgus-derived CD30/TNFRSF8 protein, expressed by HEK293 , with C-His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Rat (1) Mouse (2) Rabbit (1)
Reactivity:	Human (3) mouse (1) Mouse (2)
Application:	IHC-P (1) ICC/IF (3) IF-Tissue (1) IP (1) WB (4) FC (3) ELISA (2)
Isotype:	IgG (1) IgG1 (2) IgG2b (1)
Conjugation:	Non-conjugated (4) Biotin (3)
Clonality:	Monoclonal (2) Recombinant (1)
Modification:	Unmodified (3)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81645

	CD30 Antibody (YA1390) cd30; D1S166E; KI1; Tnfrsf8	WB, IHC-P	Human
	CD30 Antibody (YA1390) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD30.

HY-P84240

	CD30 Antibody (YA3937) Ki-1; D1S166E,TNFRSF8	WB, ICC/IF, FC, ELISA	Human, Mouse
	CD30 Antibody (YA3937) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD30.

HY-P84240A

	CD30 Antibody (YA3937)(PBS only) Ki-1; D1S166E,TNFRSF8	WB, ICC/IF, FC, ELISA	Human, Mouse
	CD30 Antibody (YA3937) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD30.

HY-P810174

	CD30L Antibody (YA9518)	WB, ICC/IF, IF-Tissue, FC, IP	mouse
	CD30L Antibody (YA9518) is a Rat-derived and non-conjugated IgG2b monoclonal antibody, targeting to CD30L.